Get your full text copy in PDF
Jürgen J Kaden
Ann Transplant 2002; 7(3): 4-10
Induction therapy for organ transplantation using monoclonal antibodies has been in recent years reevaluated. Results from various centers indicate the value of such therapy, especially in sensitized patients undergoing kidney transplantation as well as in simultaneous kidney--pancreas transplant patients. Author presents the experience of eleven years of intraoperative ATG bolus administration in the Berlin--Friedrichshain Kidney Transplantation Center.